Chronic myeloid leukemia: A summary

Authors

  • Rogério Almeida Machado
  • Ituane Monção Lopes
  • Suana Millen Bruzaca Mota
  • Gisely da Silva Reis
  • Jefferson de Lima Paz
  • Ana Kallyne Brito Sales
  • Sara Tamiris Costa Carneiro
  • Margareth Diniz Rocha
  • Diana Santos da Silva
  • Carlos Henrique de Barros da Costa Sobrinho
  • Daniely de Jesus da Costa Carvalho
  • Jessica Maria Rocha da Silva

DOI:

https://doi.org/10.56238/isevjhv3n4-002

Keywords:

Leukemia, Throne cell, Bone marrow

Abstract

Chronic myeloid leukemia (CML) occurs when the pluripotent stem cell undergoes malignant transformation and clonal myeloproliferation, causing overproduction of mature and immature granulocytes. Initially asymptomatic, the progression of chronic myeloid leukemia is insidious, with a non-specific "benign" stage (weakness, anorexia, weight loss), it ends up paving the way for an accelerated or blast phase with more dangerous signs, such as splenomegaly, pallor, easy bruising and bleeding, fever, lymphadenopathy and skin changes.

Published

2024-07-04

How to Cite

Machado, R. A., Lopes, I. M., Mota, S. M. B., Reis, G. da S., Paz, J. de L., Sales, A. K. B., Carneiro, S. T. C., Rocha, M. D., da Silva, D. S., Sobrinho, C. H. de B. da C., Carvalho, D. de J. da C., & da Silva, J. M. R. (2024). Chronic myeloid leukemia: A summary. International Seven Journal of Health Research, 3(4), 1014–1016. https://doi.org/10.56238/isevjhv3n4-002